Alcidion Group Limited Stock: price and insider trades · Australia

Alcidion Group Limited is a Health Care company. Its directors and officers file their transactions with ASX. Over the twelve months to 23 October 2026, 4 filings were filed, from 3 insiders.

Every open-market trade in the period is a purchase: 3 purchases worth €12k, from 2 insiders, and not a single sale. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 2 senior executives. At €6,143, the purchase published on 27 August 2026 by Andrew Way is the largest of the period.

Across the 1,594 companies tracked on its exchange, the median is 4 filings; at 4 filings, this issuer sits right on that mark. Looking back to 2026, when coverage begins, insiders filed 3 purchases and no sales.

The last purchase on record was published on 7 October 2026, which is 31 days ago.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. This summary is built from ASX disclosures alone and does not predict where the share price will go.